COMMUNIQUÉS West-GlobeNewswire

Transactions under Novozymes’ stock buyback program
20/05/2019
Please read the full announcement in the attached PDF Attachment 2019_13_Stock_Buybackprogram_EN
TOMI Environmental Solutions, Inc. Reports First Quarter Financial Results
20/05/2019
BEVERLY HILLS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX:TOMZ), a global company specializing in disinfection and decontamination essentials, announced its results for [...]
SetPoint Medical Reports New Data Demonstrating its Bioelectronic Medicine Effectively Reduces Crohn’s Disease Activity
20/05/2019
Results Delivered in Oral Presentation at Digestive Disease Week 2019 VALENCIA, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic [...]
Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule
20/05/2019
Hamilton, Bermuda, May 20, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]
Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
20/05/2019
UTRECHT, Netherlands, May 20, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]
Teladoc Health Establishes First and Only Patient Safety Organization (PSO) for Virtual Care
20/05/2019
Listed through the Agency for Healthcare Research and Quality HHS, the PSO will develop and execute industry-leading quality and safety initiatives PURCHASE, NY, May 20, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: [...]
AIT Therapeutics Announces Oral and Poster Presentations at the International Society for Aerosols in Medicine 2019 Congress in Montreux, Switzerland
20/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
20/05/2019
Valby, Denmark, 20 May 2019 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1. Details of [...]
Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
20/05/2019
- Humanity & Health Research Centre conducting differentiated Phase 2a study evaluating CC-31244 for the ultra-short treatment of hepatitis C (HepC) - Asia market represents one of the largest HepC virus carrier [...]
BeyondSpring Abstract Demonstrating Bone Pain Benefit with Lead Asset, Plinabulin, versus Neulasta for Neutropenia Prevention Presented at ISPOR 2019
20/05/2019
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Company’s abstract on [...]
Akorn to Present at the RBC Capital Markets Healthcare Conference
20/05/2019
LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that management will present at the 2019 RBC Capital Markets Healthcare [...]
Gloucestershire Hospitals NHS Foundation Trust selects Allscripts Sunrise™ to Continue its Digital Journey
20/05/2019
Allscripts to deliver digital solutions to improve patient care and enhance clinical outcomes CHICAGO, May 20, 2019 (GLOBE NEWSWIRE) -- Gloucestershire Hospitals NHS Foundation Trust has selected Allscripts (NASDAQ: [...]
SubioMed™ Announces Management Team Appointments
20/05/2019
Accomplished Executives and Industry Veterans Join Company Founded on Patented Inventions by Dr. Barry Butler, DPM Practicing Podiatrist and Serial Inventor MINNEAPOLIS, May 20, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc [...]
Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1536 at the 2019 American Society of Clinical Oncology Annual Meeting
20/05/2019
CAMBRIDGE, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Establishment Labs to Present at Jefferies 2019 Healthcare Conference
20/05/2019
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
20/05/2019
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and [...]
Principia Presents Phase 1 Data of PRN1371 in Patients with Metastatic Bladder Cancer
20/05/2019
-- FGFR inhibitor PRN1371 well tolerated in 36 patients in dose-escalation phase; dose expansion in metastatic urothelial carcinoma patients ongoing -- SOUTH SAN FRANCISCO, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- [...]
TYME Announces Notification of Issuance of U.S. Patent Covering SM-88 Single Agent Treatment for Cancers
20/05/2019
Complements strong patent portfolio covering SM-88 in use with other conditioning agents NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing [...]
resTORbio Presents Additional Phase 2b Data at the American Thoracic Society International Conference for RTB101 as a Potential Immunotherapy to Reduce the Incidence of Respiratory Tract Infections in Patients 65 Years of Age and Older with Asthma
20/05/2019
RTB101 10 mg once daily was observed to reduce the rate of laboratory-confirmed Respiratory Tract Infections (RTIs) by 78.7% (p=0.001) and the rate of all RTIs (with or without laboratory confirmation) by 66.4% (p=0.003 [...]

Pages